Alzex Neuropharma Statistics

Total Valuation

TRRI has a market cap or net worth of 452.

Market Cap	452
Enterprise Value	n/a

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

TRRI has 1.51 million shares outstanding.

Current Share Class	1.51M
Shares Outstanding	1.51M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	n/a

Valuation Ratios

The trailing PE ratio is 0.01.

PE Ratio	0.01
Forward PE	n/a
PS Ratio	0.00
PB Ratio	0.00
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	0.00
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.43, with a Debt / Equity ratio of 0.60.

Current Ratio	1.43
Quick Ratio	1.40
Debt / Equity	0.60
Debt / EBITDA	67.41
Debt / FCF	n/a
Interest Coverage	-6.67

Financial Efficiency

Return on equity (ROE) is 2.85% and return on invested capital (ROIC) is -1.86%.

Return on Equity (ROE)	2.85%
Return on Assets (ROA)	-1.64%
Return on Invested Capital (ROIC)	-1.86%
Return on Capital Employed (ROCE)	-3.25%
Weighted Average Cost of Capital (WACC)	0.84%
Revenue Per Employee	430,366
Profits Per Employee	2,914
Employee Count	11
Asset Turnover	2.25
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -99.85% in the last 52 weeks. The beta is -53.60, so TRRI's price volatility has been lower than the market average.

Beta (5Y)	-53.60
52-Week Price Change	-99.85%
50-Day Moving Average	0.12
200-Day Moving Average	0.28
Relative Strength Index (RSI)	42.26
Average Volume (20 Days)	2,132

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	0.00

Income Statement

In the last 12 months, TRRI had revenue of 4.73 million and earned 32,053 in profits.

Revenue	4.73M
Gross Profit	430,143
Operating Income	-55,149
Pretax Income	32,053
Net Income	32,053
EBITDA	9,232
EBIT	-55,149
Earnings Per Share (EPS)	n/a

Full Income Statement

Balance Sheet

The company has 112,836 in cash and 622,324 in debt, giving a net cash position of -509,488 or -0.34 per share.

Cash & Cash Equivalents	112,836
Total Debt	622,324
Net Cash	-509,488
Net Cash Per Share	-0.34
Equity (Book Value)	1.05M
Book Value Per Share	n/a
Working Capital	87,446

Full Balance Sheet

Cash Flow

Operating Cash Flow	286,416
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 9.09%, with operating and profit margins of -1.16% and 0.68%.

Gross Margin	9.09%
Operating Margin	-1.16%
Pretax Margin	0.68%
Profit Margin	0.68%
EBITDA Margin	0.20%
EBIT Margin	-1.16%
FCF Margin	n/a

Dividends & Yields

TRRI does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	7,091.37%
FCF Yield	n/a

Stock Splits

The last stock split was on September 18, 2015. It was a reverse split with a ratio of 0.0033333.

Last Split Date	Sep 18, 2015
Split Type	Reverse
Split Ratio	0.0033333

Scores

TRRI has an Altman Z-Score of 3.46 and a Piotroski F-Score of 5.

Altman Z-Score	3.46
Piotroski F-Score	5